相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin-triggered proresolving mediators stimulate resolution in cancer
Molly M. Gilligan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials
Tarek Haykal et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Ilya G. Serebriiskii et al.
NATURE COMMUNICATIONS (2019)
The aspirin in reducing events in the elderly trial: Statistical analysis plan
Rory Wolfe et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Pierre Michel et al.
DIGESTIVE AND LIVER DISEASE (2018)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis
Mei-Xia Wang et al.
CANCER MEDICINE (2018)
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
Marilena Petrera et al.
BMC CANCER (2018)
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
John J. McNeil et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the US Preventive Services Task Force
Jessica Chubak et al.
ANNALS OF INTERNAL MEDICINE (2016)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo
ANNALS OF INTERNAL MEDICINE (2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Christopher Coyle et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
Asad Umar et al.
SEMINARS IN ONCOLOGY (2016)
Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer
Zongli Xu et al.
CARCINOGENESIS (2014)
High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer
Thomas Aparicio et al.
JOURNAL OF GERIATRIC ONCOLOGY (2014)
Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial
Nancy R. Cook et al.
ANNALS OF INTERNAL MEDICINE (2013)
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
R. H. Grimm et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Reiko Nishihara et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials
Edward J. Mills et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Aspirin and immune system
Muzammal Hussain et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer - The ASCOLT study: Study Protocol for a randomized controlled trial
Raghib Ali et al.
TRIALS (2011)
Evaluating the Age Distribution of Patients With Colorectal Cancer: Are the United States Preventative Services Task Force Guidelines for Colorectal Cancer Screening Appropriate?
Jason K. Shellnut et al.
DISEASES OF THE COLON & RECTUM (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
分享论文
